---
title: "BUZZ-Kenvue tumbles after report RFK Jr. links autism risk in tylenol use"
description: "Shares of Kenvuefell 10% to $18.46 following a report that Health Secretary Robert F. Kennedy Jr. will release a government report linking Tylenol use during pregnancy to autism. Kenvue, which produce"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256177025.md"
published_at: "2025-09-05T18:10:02.000Z"
---

# BUZZ-Kenvue tumbles after report RFK Jr. links autism risk in tylenol use

> Shares of Kenvuefell 10% to $18.46 following a report that Health Secretary Robert F. Kennedy Jr. will release a government report linking Tylenol use during pregnancy to autism. Kenvue, which produces Tylenol, maintains that there is no causal link between acetaminophen use and autism. The stock is down 12% year-to-date.

Shares of consumer healthcare co Kenvue (KVUE.N) fall 10% to $18.46

U.S. Health Secretary Robert F. Kennedy Jr. plans to release government report linking Tylenol use during pregnancy to autism, The Wall Street Journal reports, citing people familiar with matter

Tylenol, whose active ingredient is acetaminophen, is made by Kenvue and is widely used for pain relief, including by pregnant women

Report will also suggest medicine derived from folate, called folinic acid, can be used to treat symptoms of the disorder in some people, WSJ adds

Speaking on WSJ report, Kenvue says it continues to believe there is no causal link between acetaminophen use during pregnancy and autism, CNBC reports

Including session’s moves, stock down 12% YTD

### Related Stocks

- [KVUE.US - Kenvue](https://longbridge.com/en/quote/KVUE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Kenvue｜8-K：2025 财年 Q4 营收 37.8 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276173539.md) |
| ZAWYA-PRESSR: Kenvue 将皮肤病学的科学研究和专业教育引入 JeddaDerm | Kenvue，最大的纯消费健康公司，于 2026 年 2 月 11 日至 14 日在沙特阿拉伯吉达的 JeddaDerm 展会上展示了其皮肤科专业知识。此次活动讨论了皮肤健康和护发，包括米诺地尔的临床作用以及胶原蛋白储存等创新方法。Kenv | [Link](https://longbridge.com/en/news/276003935.md) |
| 周四，Neutrogena 制造商 Kenvue 的股票情况如何？ | Kenvue Inc.（纽约证券交易所代码：KVUE）在盘前交易中股价下跌 0.32%，报 18.48 美元。投资者批准了其出售给 Kimberly-Clark 的计划，99% 的投票支持该交易。收购预计将在 2026 年下半年完成。Ken | [Link](https://longbridge.com/en/news/275771763.md) |
| Starboard Value 提高了在 Kenvue 和 Riot Platforms 的持股比例 | 激进投资者 Starboard Value LP 在 12 月季度增加了对 Riot Platforms 和 Kenvue 的持股，同时减少了对其他几家公司的持股。Starboard 还计划推动 Tripadvisor 董事会的重大改革，准 | [Link](https://longbridge.com/en/news/276180436.md) |
| Kenvue 的举措预计将导致员工减少 3.5% | Kenvue 的举措预计将导致 3.5% 的员工减少 | [Link](https://longbridge.com/en/news/276175855.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.